Medivation spikes lower after court case loss, levels to watch The stock is down over 4.7% at time of writing following new that the summary ruling that denied the company rights to Aragon's ARN-509. Next support is at $48.67. Resistance is at $50.10.
News For MDVN From The Last 14 Days
Check below for free stories on MDVN the last two weeks.